Evidence map›Paper›PMID 41190618›Full record

Observational studyEuropean journal of neurology2025

Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage.

Simón Cárdenas-Robledo, Susana Otero-Romero, Juan David García, Nuria López, Pere Carbonell-Mirabent, Marta Rodríguez, Claudia Guío-Sánchez, René Carvajal, Maria Angels Passarell-Bacradit, Jaume Sastre-Garriga and 2 more

Abstract readObservational Study
In one paragraph

Observational study in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Simón Cárdenas-RobledoCentro de Esclerosis Múltiple (CEMHUN), Hospital Universitario Nacional de Colombia, Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0002-7612-3985
Susana Otero-RomeroNeurology-Neuroimmunology Service, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall D'hebron, Barcelona, Spain.ORCID 0000-0002-6798-568X
Juan David GarcíaDepartamento de Imágenes Diagnósticas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Nuria LópezCognitive Impairment and Dementia Unit, Hospital Atenció Intermedia Mutuam Güell, Grup Mutuam, Barcelona, Spain.
Pere Carbonell-MirabentNeurology-Neuroimmunology Service, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall D'hebron, Barcelona, Spain.
Marta RodríguezNeurology-Neuroimmunology Service, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall D'hebron, Barcelona, Spain.
Claudia Guío-SánchezFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic/Manresa, Catalonia, Spain.ORCID 0000-0002-2966-8368
René CarvajalFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic/Manresa, Catalonia, Spain.ORCID 0000-0003-3583-8412
Maria Angels Passarell-BacraditAtención Primaria/IDIAP Jordi Gol Primary Care Research Institute, Institut Catalá de la Salut, Barcelona, Spain.
Jaume Sastre-GarrigaNeurology-Neuroimmunology Service, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall D'hebron, Barcelona, Spain.ORCID 0000-0002-1589-2254
Xavier MontalbanFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic/Manresa, Catalonia, Spain.ORCID 0000-0002-0098-9918
Mar TintoréFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic/Manresa, Catalonia, Spain.ORCID 0000-0001-9999-5359

Funding

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)Institut Universitari d'Investigació en Atenció Primària (IDIAP) Jordi Gol
6 · The paper itself

Abstract

introductionMS patients are at increased risk of comorbidities and use more healthcare resources. Multimorbidity approached as the number of conditions is flawed by classifying patients with different needs as equal. We aimed to explore how comorbidities cluster and their impact on healthcare resource usage.

methodsWe used latent-class models of up to 10 clusters in a population-based sample of MS patients. The optimal number of clusters was determined using model metrics and similarity/entropy measures, and cluster stability was assessed by bootstrapping. Sociodemographic characteristics and healthcare-resource usage according to the clusters assigned were compared to each other and to patients without comorbidities using univariable and adjusted linear regression models.

resultsIn 5548 MS cases, of which 60% had comorbidities, the optimal number of comorbidity clusters was two, comprising a high frequency of cardiovascular comorbidities and psychiatric disorders. Patients in the cardiovascular cluster were older, and in the psychiatric cluster were more frequently female. After adjusting for sociodemographic variables, healthcare resource usage was higher for patients with comorbidities, particularly for nurse (1.1 more average yearly visit; [95% CI 0.41-1.8]; p = 0.002), primary care (1.8 more visits; [95% CI 1.4-2.1]; p < 0.001), and medication dispensation (336 more dosage units; [95% CI 260-402]; p < 0.001) in the cardiovascular cluster, and annual sick-leave days (3.8 more days; [95% CI 0.25-7.3]; p = 0.036) in the psychiatric cluster. DISCUSSION: We observed clustering of comorbidities around cardiovascular comorbidities and mental disorders, which impacted healthcare resource usage differently. Further research is needed to assess the influence of these clusters on the prognosis of MS.

Indexed as

ComorbidityHealth ResourcesMultiple SclerosisAdultCardiovascular DiseasesCluster AnalysisCross-Sectional StudiesFemaleHumansMaleMental DisordersMiddle AgedSociodemographic FactorsSpaincardiovascular diseasesclusteringcomorbidityhealthcare resource usagelatent class analysismental disordersmultiple sclerosis

Identifiers

PMID41190618
PMCPMC12587307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.